| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/15/2010 | DE102009017716A1 New polypeptide comprising a variable domain of heavy chain of human or camelids antibody, a constant domain of light chain and optionally a linker, useful for diagnosis, treatment and/or prevention of infections associated with e.g. HIV |
| 07/15/2010 | DE102007042107B4 Pharmazeutische Zusammensetzung mit eisenbindendem Agens A pharmaceutical composition comprising eisenbindendem agent |
| 07/15/2010 | CA2752490A1 Complex and production process |
| 07/15/2010 | CA2750227A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection |
| 07/15/2010 | CA2749537A1 Therapeutic compositions for treatment of corneal disorders |
| 07/15/2010 | CA2749180A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 07/15/2010 | CA2749143A1 Compositions for enhancing nail growth |
| 07/15/2010 | CA2749141A1 Cyclosporine compositions for enhancing nail growth |
| 07/15/2010 | CA2749099A1 Method for treating hyperglycemia with glp-1 |
| 07/15/2010 | CA2749082A1 Targeted antimicrobial moieties |
| 07/15/2010 | CA2749047A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | CA2749034A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| 07/15/2010 | CA2748792A1 Combination of a cyclosporine derivative and nucleosides for treating hcv |
| 07/15/2010 | CA2748449A1 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 07/15/2010 | CA2748392A1 Use of interleukin-22 for the prevention and/or treatment of multiple organ dysfunction syndrome (mods) |
| 07/15/2010 | CA2747720A1 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor |
| 07/15/2010 | CA2747611A1 Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
| 07/15/2010 | CA2747490A1 Insulin analogs |
| 07/15/2010 | CA2747248A1 Hepatitis c virus combination therapy |
| 07/15/2010 | CA2747195A1 Dipeptide linked medicinal agents |
| 07/15/2010 | CA2747192A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/15/2010 | CA2747154A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | CA2747011A1 Nkg2d-fc for immunotherapy |
| 07/15/2010 | CA2746976A1 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 07/15/2010 | CA2746968A1 Octreotide depot formulation with constantly high exposure levels |
| 07/15/2010 | CA2744558A1 Amide-based insulin prodrugs |
| 07/15/2010 | CA2744235A1 Treatment of mucositis with kallikrein inhibitors |
| 07/14/2010 | EP2206786A1 Novel proteases and variants thereof |
| 07/14/2010 | EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 07/14/2010 | EP2206726A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/14/2010 | EP2206725A1 Analogs of parathyroid hormone |
| 07/14/2010 | EP2206721A1 Neuromedin u derivative |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor |
| 07/14/2010 | EP2206518A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor |
| 07/14/2010 | EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies |
| 07/14/2010 | EP2206512A2 Increase of interferon-beta for anti-virus therapy for respiratory diseases |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2206510A1 Therapeutic agent for diabetes |
| 07/14/2010 | EP2205733A1 Methods for producing a non human animal model for aortic aneurysm |
| 07/14/2010 | EP2205723A1 Method of initiating cardiomyocyte differentiation |
| 07/14/2010 | EP2205722A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage |
| 07/14/2010 | EP2205629A2 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 07/14/2010 | EP2205627A1 Anticomplement polypeptides of ixodes ricinus |
| 07/14/2010 | EP2205626A2 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 07/14/2010 | EP2205271A1 Compositions and methods for ribonuclease-based therapies |
| 07/14/2010 | EP2205270A1 Peptides based on the sequence of human lactoferrin and their use |
| 07/14/2010 | EP2205269A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 07/14/2010 | EP2205268A1 Interferon alpha sequential regimen for treating cancers |
| 07/14/2010 | EP2205267A1 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent |
| 07/14/2010 | EP2205265A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 07/14/2010 | EP2205264A1 Molecular delivery vesicle |
| 07/14/2010 | EP2205262A2 Use of melanotropin-potentiating factor as a therapeutic agent |
| 07/14/2010 | EP2205259A1 Method of regulating the th17 pathway and its associated metabolic impact |
| 07/14/2010 | EP2205257A2 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 07/14/2010 | EP2205256A2 Reagents for inducing an immune response |
| 07/14/2010 | EP2205235A2 Formulation to improve gastrointestinal function |
| 07/14/2010 | EP2205228A2 Patch for cutaneous application, which comprises a hydrophile powder |
| 07/14/2010 | EP2205219A1 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 07/14/2010 | EP2205217A1 Orally bioavailable lipid-based constructs |
| 07/14/2010 | EP2205071A1 Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and trkb agonists |
| 07/14/2010 | EP1868631B1 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition |
| 07/14/2010 | EP1851536B1 Stable glucose oxidase formulations and methods for making and using them |
| 07/14/2010 | EP1585524B1 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 07/14/2010 | EP1514116B9 Oxaliplatin anti-resistance method |
| 07/14/2010 | EP1513859B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 07/14/2010 | EP1424995B1 A bio-security system |
| 07/14/2010 | EP1416977B1 Device for regeneration of articular cartilage and other tissue |
| 07/14/2010 | EP1222226B1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/14/2010 | EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/14/2010 | EP1079859B1 Bifunctional molecules and therapies based thereon |
| 07/14/2010 | CN1911102B Compounding agent for sobering and health-care, and its production method |
| 07/14/2010 | CN1910283B Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 07/14/2010 | CN101778862A Rapid acting insulin analogues |
| 07/14/2010 | CN101778639A Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 07/14/2010 | CN101778576A stabilized anthocyanin compositions |
| 07/14/2010 | CN101776680A Schistosoma japonicum fluke resistance medicine effect target and medicine sieving method |
| 07/14/2010 | CN101775429A Whey protein antioxidant peptides, preparation method thereof and application thereof |
| 07/14/2010 | CN101775401A Rana chensinensis functional gene Rd-RNase3 sequence, construction method and amino acid sequence and application thereof |
| 07/14/2010 | CN101775400A Rana chensinensis functional gene Rd-RNase2 sequence, construction method and amino acid sequence and application thereof |
| 07/14/2010 | CN101775082A Amphoteric ion-based charge reversal chitosan derivative and application thereof in medicament |
| 07/14/2010 | CN101775073A Drug for inhibiting proliferation of tumor cells and application thereof |
| 07/14/2010 | CN101775072A Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides |
| 07/14/2010 | CN101775068A Novel natural antibacterial peptides, and coding sequence and uses thereof |
| 07/14/2010 | CN101775067A New synthesized antibacterial peptide as well as preparation method and application thereof |
| 07/14/2010 | CN101773671A Application of shRNA (short hairpin Ribonucleic Acid) of Periostin gene in preparing medicament for inhibiting tumor |
| 07/14/2010 | CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/14/2010 | CN101773665A Reproductive protective agent facilitating human fertilization |
| 07/14/2010 | CN101773664A Fish bone scale collagen peptide for preventing and curing egg and poultry fracture |
| 07/14/2010 | CN101773663A New application of collagen chelate |
| 07/14/2010 | CN101773662A Water soluble gel for treating burn and scald |
| 07/14/2010 | CN101773661A 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| 07/14/2010 | CN101773660A Medicament containing anubi-polypeotide |
| 07/14/2010 | CN101773513A Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
| 07/14/2010 | CN101773476A Preparation method for laver antihypertensive peptide particles |
| 07/14/2010 | CN101773473A Preparation method of supercritical antisolvent of nano-insulin powder |
| 07/14/2010 | CN101773463A Selenium-enriched nano pearl powder formula and production method thereof |
| 07/14/2010 | CN101255190B Use of human midkine protein blocking peptide in preparation of antitumor medicament |
| 07/14/2010 | CN101112391B Application of HGF transgenic bone marrow stroma stem cell in the preparation of bone restoring material |
| 07/13/2010 | US7754885 tubulysin derivatives used as antitumor agents |